Senior insider sale
Chief Development Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$4.66M
161K shares
What this filing means
MYLES DAVID C. plans to sell 161K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $4.66M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2026ACC: 0001959173-26-000307
Officer· Chief Development Officer
Since Nov 2020
161K
Shares to sell
$4.66M
Approx. market value
50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Option Granted 02/01/2023
Cash
1/14/2026
50KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/14/2026 | Option Granted 02/01/2023 Cash | 50K | — |
| Total | 50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
50K
Market value
$1.38M
1/13/2026
—Completed
Units to sell
10K
Market value
$283.4K
1/12/2026
—Completed
Units to sell
51K
Market value
$1.55M
12/19/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$1.44M
1/14/2026
Total
Units
161K
Value
$4.66M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/13/2026 | 50K | $1.38M | — | Completed |
1/12/2026 | 10K | $283.4K | — | Completed |
12/19/2025 | 51K | $1.55M | — | Completed |
| Planned — Approximate Date | ||||
1/14/2026 | 50K | $1.44M | NASDAQ | Planned |
| Total | 161K | $4.66M | ||